RESUMEN
BACKGROUND:Studies have found that liver cels can synthesize insulin after giving pancreatic and duodenal homeobox 1 (PDX1) gene. Anti-CD20 monoclonal antibody can inhibit the immune reaction of insulin-producing liver cels, but the mechanism is unclear. OBJECTIVE:To observe the influence of interleukin-10 gene on liver cels and liver PDX1 expression in nonobese diabetic mice after interfered by adenovirus vector-mediated murine interleukin-10 and anti-CD20 monoclonal antibody. METHOD:Forty nonobese diabetic female mice aged 3-5 weeks were randomly divided into anti-CD20, anti-CD20 + interleukin-10, interleukin, and control groups. Mice in each group were respectively injected with anti-CD20 monoclonal antibody, anti-CD20 monoclonal antibody + adenovirus vector-mediated murine interleukin-10, adenovirus vector-mediated murine interleukin-10 and normal saline on days 1, 8, 15 and 21via tail vein. RESULTS AND CONCLUSION:At 12 weeks, the blood glucose level of mice treated with anti-CD20 monoclonal antibody and/or interleukin-10 was significantly reduced compared with the control group, while the insulin, interleukin-10 and CD20 expression levels in the serum and liver were significantly increased, the liver PDX1 expression was also upregulated. Anti-CD20 monoclonal antibody with interleukin-10 had more obvious effects than the single use. No matter the combined intervention or single use, anti-CD20 monoclonal antibody and interleukin-10 show no impact on the inflammation of liver cels. Anti-CD20 monoclonal antibody and/or interleukin-10 increases PDX1 expression in nonobese diabetic mice.
RESUMEN
Objetivos: revisar dados da literatura sobre isolamento de ilhotas pancreáticas para transplante e sobre as ações da frutose-1,6-bisfosfato. Fonte de dados: revisão de artigos publicados, a partir da pesquisa em bancos de dados nacionais e internacionais (SciELO, Lilacs, PubMed). Síntese dos dados: o transplante de ilhotas surge como uma alternativa para o tratamento do diabetes mellitus tipo 1. Entretanto, durante o processo de isolamento, há grande perda celular, principalmente na periferia da ilhota pancreática. As espécies reativas de oxigênio contribuem significativamente nesse processo, afetando a viabilidade das células para transplante. Vários esforços estão sendo feitos na tentativa de minimizar os danos causados pela liberação e produção destes compostos químicos. Conclusões: frente às importantes ações da frutose-1,6-bisfosfato descritas na literatura, seu emprego durante o processo de isolamento das ilhotas pancreáticas parece ser uma alternativa bastante atraente. O efeito da frutose-1,6-bisfosfato na redução da formação e liberação de radicais livres, assim como a sua ação citoprotetora, poderiam viabilizar um maior número de células, otimizando o processo de isolamento, além de auxiliar na enxertia, por diminuir a liberação de citocinas pró-inflamatórias.
Aims: To review the literature data about pancreatic islet isolation and fructose-1,6-bisphosfate. Source of data: Review of specific articles on the issue published in national and internacional databases (SciELO,Lilacs, PubMed). Summary of findings: Islets transplantation is an alternative for the treatment of type 1 diabetes mellitus. However, during the process of isolation, cell loss, mainly on the periphery of the pancreatic islet, ensues. Reactive oxygen species seem to contribute significantly in this process, affecting the viability of these cells. Various efforts are being made in an attempt to minimize the damage caused by the release and production of reactive oxygen species. Conclusions: Considering the important actions of fructose-1,6-bisphosphate which are described in the literature, its use in pancreatic islet isolation may represent an attractive alternative. The effect of fructose-1,6-bisphosphate in reducing the production and release of free radicals, as well as its role in cellular protection, could enable a greater number of viable cells, optimizing the isolation process, and also protecting the graft process, by reducing the release of proinflammatory cytokines.